Peter G. Sørensen

2.6k total citations
43 papers, 1.1k citations indexed

About

Peter G. Sørensen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Peter G. Sørensen has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Peter G. Sørensen's work include Hematological disorders and diagnostics (7 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Peter G. Sørensen is often cited by papers focused on Hematological disorders and diagnostics (7 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Peter G. Sørensen collaborates with scholars based in Denmark, Norway and Hungary. Peter G. Sørensen's co-authors include Fred R. Hirsch, Malgorzata Tuxen, Hans C. van Houwelingen, Svend Aage Engelholm, Cristiana Sessa, C.A.M. de Swart, Birthe Lund, Mogens Hansen, Jan P. Neijt and Michael Andersson and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Peter G. Sørensen

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter G. Sørensen Denmark	16	529	353	308	225	175	43	1.1k
Patrick Berteloot Belgium	25	741 1.4×	821 2.3×	458 1.5×	347 1.5×	360 2.1×	88	2.0k
Mark George United Kingdom	16	649 1.2×	74 0.2×	387 1.3×	157 0.7×	211 1.2×	33	1.5k
Veronika Seebacher Austria	18	434 0.8×	209 0.6×	353 1.1×	220 1.0×	138 0.8×	46	1.0k
Lionel Duck Belgium	11	490 0.9×	76 0.2×	313 1.0×	279 1.2×	47 0.3×	33	837
Nicholas Reed United Kingdom	19	426 0.8×	655 1.9×	401 1.3×	369 1.6×	74 0.4×	45	1.6k
Ossi R. Koechli Switzerland	18	442 0.8×	158 0.4×	386 1.3×	106 0.5×	301 1.7×	26	1.1k
J. F. Pringle Canada	18	480 0.9×	355 1.0×	363 1.2×	310 1.4×	247 1.4×	22	1.3k
Onelio Geatti Italy	18	365 0.7×	56 0.2×	376 1.2×	261 1.2×	103 0.6×	50	1.3k
C. Oberhoff Germany	16	454 0.9×	48 0.1×	82 0.3×	234 1.0×	164 0.9×	45	1.1k
Pınar Saip Türkiye	21	606 1.1×	316 0.9×	337 1.1×	520 2.3×	354 2.0×	115	1.6k

Countries citing papers authored by Peter G. Sørensen

Since Specialization

Citations

This map shows the geographic impact of Peter G. Sørensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Sørensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Sørensen more than expected).

Fields of papers citing papers by Peter G. Sørensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter G. Sørensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Sørensen. The network helps show where Peter G. Sørensen may publish in the future.

Co-authorship network of co-authors of Peter G. Sørensen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter G. Sørensen. A scholar is included among the top collaborators of Peter G. Sørensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter G. Sørensen. Peter G. Sørensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adam, Iris, et al.. (2021). Syringeal vocal folds do not have a voice in zebra finch vocal development. Scientific Reports. 11(1). 6469–6469. 6 indexed citations

Kümler, Iben, Rikke Løvendahl Eefsen, Peter G. Sørensen, et al.. (2019). An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine. Cancer Chemotherapy and Pharmacology. 84(2). 441–446. 5 indexed citations

Kümler, Iben, Peter G. Sørensen, Jesper Andreas Palshof, et al.. (2018). Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics. Cancer Chemotherapy and Pharmacology. 83(1). 169–178. 11 indexed citations

Pedersen, Anders N., Susanne Möller, Karina Dahl Steffensen, et al.. (2010). Supraclavicular recurrence after early breast cancer: a curable condition?. Breast Cancer Research and Treatment. 125(3). 815–822. 32 indexed citations

Ejlertsen, Bent, Maj‐Britt Jensen, Henning T. Mouridsen, et al.. (2008). DBCG trial 89B comparing adjuvant CMF and ovarian ablation: Similar outcome for eligible but non-enrolled and randomized breast cancer patients. Acta Oncologica. 47(4). 709–717. 3 indexed citations

Andersson, Michael, Dorthe Susanne Nielsen, Peter G. Sørensen, & Marianne Ewertz. (2007). Phase II trial of vinorelbine (V) days 1+8 every 3 weeks and trastuzumab (T) weekly as first-line chemotherapy for HER2+ metastatic breast cancer (MBC). Journal of Clinical Oncology. 25(18_suppl). 1091–1091. 1 indexed citations

Hansen, Olfred, et al.. (2005). [Curative radiotherapy of local advanced non-small-cell lung cancer. Eight years of experience from Odense].. PubMed. 167(37). 3497–502. 2 indexed citations

Pedersen, Lars Møller & Peter G. Sørensen. (2003). Urinary Albumin Excretion is a Predictor of Response to Treatment and Disease Progression in Low-Grade non-Hodgkin's Lymphoma. Leukemia & lymphoma. 45(3). 547–551. 7 indexed citations

Hirsch, Fred R., Kell Østerlind, P Dombernowsky, et al.. (2001). Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients. Annals of Oncology. 12(5). 647–653. 8 indexed citations

10.

Mouridsen, Henning T., Michael Andersson, P Dombernowsky, et al.. (1999). Adjuvant anthracycline in breast cancer. Improved outcome in premenopausal patients following substitution of methotrexate in the CMF Combination with epirubicin. European Journal of Cancer. 35. S83–S83. 48 indexed citations

11.

Pedersen, Lars Møller & Peter G. Sørensen. (1999). Clinical significance of urinary albumin excretion in patients with non‐Hodgkin's lymphoma. British Journal of Haematology. 107(4). 889–891. 16 indexed citations

12.

Jensen, Kim Ebensgaard, Peter G. Sørensen, C. Thomsen, et al.. (1990). Prolonged T1 Relaxation of the Hemopoietic Bone Marrow in Patients with Chronic Leukemia. Acta Radiologica. 31(5). 445–448. 7 indexed citations

13.

Groth, S., H Johansen, Peter G. Sørensen, & Niels Nygaard Rossing. (1989). The Effect of Thoracic Irradiation for Cancer of the Breast on Ventilation, Perfusion and Pulmonary Permeability: A one-Year Follow-Up. Acta Oncologica. 28(5). 671–678. 21 indexed citations

14.

Jensen, Karl Erik, H K Nielsen, C. Thomsen, et al.. (1989). In Vivo Measurements of the T1 Relaxation Processes in the Bone Marrow in Patients with Myelodysplastic Syndrome. Acta Radiologica. 30(4). 365–368. 5 indexed citations

15.

Jensen, Karl Erik, Carsten Thomsen, Peter G. Sørensen, et al.. (1988). Prolonged bone marrow T1-relaxation in patients with polycythemia vera. Magnetic Resonance Imaging. 6(3). 291–292. 13 indexed citations

16.

Thomsen, Carsten, Peter G. Sørensen, Hans Karle, Per Christoffersen, & Ole Henriksen. (1987). Prolonged bone marrow T1-relaxation in acute leukaemia. In vivo tissue characterization by magnetic resonance imaging. Magnetic Resonance Imaging. 5(4). 251–257. 52 indexed citations

17.

Sørensen, Peter G., Niels Nygaard Rossing, & Mikael Rørth. (1985). Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.. PubMed. 66(5). 333–40. 24 indexed citations

18.

Sørensen, Peter G., Frode K. Rømer, & Dina Cortes. (1984). Angiotensin-converting enzyme: an indicator of bleomycin-induced pulmonary toxicity in humans?. European Journal of Cancer and Clinical Oncology. 20(11). 1405–1408. 6 indexed citations

19.

Sørensen, Peter G., S. Groth, Steen Werner Hansen, & H Dirksen. (1984). Ventilation/perfusion relations in patients with small cell anaplastic carcinoma of the lung, obtaining complete remission during combination chemotherapy. European Journal of Cancer and Clinical Oncology. 20(2). 233–241. 4 indexed citations

20.

Sørensen, Peter G., Mikael Rørth, Heine H. Hansen, P Dombernowsky, & Herman Høst. (1983). A phase II trial of peplomycin in squamous cell carcinoma of the lung. European Journal of Cancer and Clinical Oncology. 19(1). 25–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact